Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies

Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies

Abstract Introduction Dimethyl fumarate (DMF) showed favorable benefit-risk in patients with relapsing-remitting multiple sclerosis (MS) in phase 3 DEFINE and CONFIRM trials and in the ENDORSE extension study. Disease activity can differ in younger patients with MS compared with the overall populati...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Lilyana Amezcua, Yang Mao-Draayer, Wendy S. Vargas, Rebecca Farber, Sara Schaefer, Filipe Branco, Sarah M. England, Nicholas Belviso, James B. Lewin, Jason P. Mendoza, Sai L. Shankar, the ENDORSE Study Investigators
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: Adis, Springer Healthcare 2023-04-01
Ráidu:Neurology and Therapy
Fáttát:
Dimethyl fumarate
DMT
Efficacy
Multiple sclerosis
Safety
Young adults
Liŋkkat:https://doi.org/10.1007/s40120-023-00475-8

Interneahtta

https://doi.org/10.1007/s40120-023-00475-8

Geahča maid